BRL-186616

N/A

Report date: 2023/05/18 13:58:26
NME

Base Information

Drug NameBRL-186616
Drug Alias NameBRL-186616
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver CirrhosisLiver Cirrhosis, Biliary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBerylrx Therapeutics
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBerylrx Therapeutics
Inactive CompaniesN/A
Active IndicationsLiver CirrhosisLiver Cirrhosis, Biliary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A